World Health Organization site
Skip Navigation Links

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 4 November 2019
Main ID:  DRKS00015755
Date of registration: 06/03/2019
Prospective Registration: Yes
Primary sponsor: UMM MannheimMedizinische Klinik IISektion Altersmedizin/Geriatrisches Zentrum
Public title: DanA
Scientific title: DanA - Delirium-intervention in the acute-geriatric Setting. A non-pharmacological team-based Approach. Measurement for the early prevention, recognition and treatment of sudden confusion of older inpatients.
Date of first enrolment: 01/04/2019
Target sample size: 407
Recruitment status: Recruiting
Study type:  interventional
Study design:  Allocation: Non-randomized controlled trial;. Masking: Open (masking not used). Control: Control group receives no treatment. Assignment: Other. Study design purpose: Prevention;  
Phase:  N/A
Countries of recruitment
Name: Claudia    Eckstein
Address:  Theodor-Kutzer-Ufer 1-3 68167 Mannheim Germany
Telephone: +49 (0)621 383 2553
Affiliation:  Universitätsmedizin Mannheim, II Medizinische Universitätsklinik, Sektion Altersmedizin,
Name: Heinrich    Burkhardt-Studienleitung
Address:  Theodor-Kutzer-Ufer 1-3 68167 Mannheim Germany
Telephone: +49 (0)621 383 5981
Affiliation:  Universitätsmedizin Mannheim, II. Medizinische Universitätsklinik, Sektion Altersmedizin
Key inclusion & exclusion criteria
Inclusion criteria: Patients aged 65 and over (with and without cognitive impairments/dementia); patients with and without delirium at admission, non-ethyltoxic genesis; acute geriatric treatment.
Exclusion criteria: Patients with severely impaired communication skills; estimated hospital stay less than 48 hours.

Age minimum: 65 Years
Age maximum: 105 Years
Gender: Both, male and female
Health Condition(s) or Problem(s) studied
F05.0 - Delirium not superimposed on dementia, so described
F05.1 - Delirium superimposed on dementia
Intervention 1: Pre-intervention group (control group) = measurement of prevalence and incidence of delirium (without Intervention) Intervention 2: Intervention group = Measurement of the effect of a systematic, daily, interprofessional exchange on the prevalence and incidence of delirium.
Within the framework of this exchange, any changes and signs that may indicate a delirium are discussed and the consequences of action derived from them for the individual case are coordinated on an interprofessional basis.
Primary Outcome(s)
Aim: Further development of interprofessional teamwork. T0= before the intervention phase (03(2019); T1= after the intervention phase 11/2019 using the Assessment of Interprofessional Team Collaboration Scale (AITCS-II).
Secondary Outcome(s)
Collection of primary endpoints of delirium-incidence and prevalence by secondary analysis of routine clinical data of each included patient treated in acute-geriatric ward in the pre-intervention phase (01.10.2018-28.02.2019) and in the intervention phase (01.06.2019-31.10.2019).
Secondary ID(s)
Source(s) of Monetary Support
Netzwerk Alternsforschung (NAR) der Universität Heidelberg
UMM MannheimMedizinische Klinik IISektion Altersmedizin/Geriatrisches Zentrum
Secondary Sponsor(s)
Ethics review
Status: approved
Approval date:
(leading) Ethics Committee-No. (Medizinische Ethik-Kommission II Medizinische Fakultät Mannheim der Universität Heidelberg)
Results available:
Date Posted:
Date Completed:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history